1. Home
  2. JAGX vs XTIA Comparison

JAGX vs XTIA Comparison

Compare JAGX & XTIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • XTIA
  • Stock Information
  • Founded
  • JAGX 2013
  • XTIA 1999
  • Country
  • JAGX United States
  • XTIA United States
  • Employees
  • JAGX N/A
  • XTIA N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • XTIA
  • Sector
  • JAGX Health Care
  • XTIA
  • Exchange
  • JAGX Nasdaq
  • XTIA NYSE
  • Market Cap
  • JAGX 7.4M
  • XTIA 7.5M
  • IPO Year
  • JAGX N/A
  • XTIA N/A
  • Fundamental
  • Price
  • JAGX $5.88
  • XTIA $1.38
  • Analyst Decision
  • JAGX
  • XTIA
  • Analyst Count
  • JAGX 0
  • XTIA 0
  • Target Price
  • JAGX N/A
  • XTIA N/A
  • AVG Volume (30 Days)
  • JAGX 247.5K
  • XTIA 226.0K
  • Earning Date
  • JAGX 05-15-2025
  • XTIA 05-27-2025
  • Dividend Yield
  • JAGX N/A
  • XTIA N/A
  • EPS Growth
  • JAGX N/A
  • XTIA N/A
  • EPS
  • JAGX N/A
  • XTIA N/A
  • Revenue
  • JAGX $11,689,000.00
  • XTIA $3,202,000.00
  • Revenue This Year
  • JAGX $22.41
  • XTIA $59.74
  • Revenue Next Year
  • JAGX $30.00
  • XTIA N/A
  • P/E Ratio
  • JAGX N/A
  • XTIA N/A
  • Revenue Growth
  • JAGX 19.75
  • XTIA N/A
  • 52 Week Low
  • JAGX $4.02
  • XTIA $0.96
  • 52 Week High
  • JAGX $502.50
  • XTIA $507.50
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 37.09
  • XTIA 46.58
  • Support Level
  • JAGX $5.30
  • XTIA $1.28
  • Resistance Level
  • JAGX $13.20
  • XTIA $1.56
  • Average True Range (ATR)
  • JAGX 1.49
  • XTIA 0.10
  • MACD
  • JAGX -0.57
  • XTIA 0.06
  • Stochastic Oscillator
  • JAGX 7.30
  • XTIA 47.06

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About XTIA XTI AEROSPACE

XTI Aerospace Inc is an aircraft development company. It also provides real-time location systems (RTLS) for the industrial sector. The company is developing a vertical takeoff and landing (VTOL) airplane that is designed to take off and land like a helicopter and cruise like a fixed-wing business airplane. Its initial configuration, the TriFan 600 airplane, will be one of the first civilian fixed-wing VTOL airplane that offers the speed and comfort of a business airplane and the range and versatility of VTOL for a wide range of customer applications, including private aviation for business and high net worth individuals, emergency medical services, and regional charter air travel. The company operates in two reportable segments: Industrial IoT and Commercial Aviation.

Share on Social Networks: